IRS2 and metabolic syndrome: A similar deterioration of adipose tissue function was also described previously in humans, where adipocyte insulin sensitivity was reduced in individuals with metabolic syndrome, with prominent alterations in the lipolysis cascade along with marked downregulation of the IRS2 gene expression [36].